Functional Crosstalk between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2

Antioxidants and Redox Signaling

Volumn 22, Issue 16, 2015, Pages 1365-1381

  Mozzetta, Chiara ^a,b   Pontis, Julien ^a   Ait Si Ali, Slimane ^a  

^a Université Sorbonne Paris Cité   (France)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; LYSINE; METHYLTRANSFERASE; POLYCOMB REPRESSIVE COMPLEX 2; EHMT1 PROTEIN, HUMAN; HISTONE LYSINE METHYLTRANSFERASE;

ADULT STEM CELL; CELL DIFFERENTIATION; CELL FATE; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE CONTROL; GENE SILENCING; HOMEOSTASIS; HUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION; REVIEW; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; ENZYME SPECIFICITY; METABOLISM;

HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; POLYCOMB REPRESSIVE COMPLEX 2; SUBSTRATE SPECIFICITY;

EID: 84929178817     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6116     Document Type: Review

References (181)

1. Ait-Si-Ali S, Guasconi V, Fritsch L, Yahi H, Sekhri R, Naguibneva I, Robin P, Cabon F, Polesskaya A, and Harel-Bellan A. A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J 23: 605-615, 2004.
2. Alder O, Lavial F, Helness A, Brookes E, Pinho S, Chandrashekran A, Arnaud P, Pombo A, O'Neill L, and Azuara V. Ring1B and Suv39h1 delineate distinct chromatin states at bivalent genes during early mouse lineage commitment. Development 137: 2483-2492, 2010.
3. Alekseyenko AA, Gorchakov AA, Kharchenko PV, Kuroda MI. Reciprocal interactions of human C10orf12 and C17orf96 with PRC2 revealed by BioTAP-XL cross-linking and affinity purification. Proc Natl Acad Sci USA 111: 2488-2493, 2014.
4. Arnold P, Scholer A, Pachkov M, Balwierz PJ, Jorgensen H, Stadler MB, van Nimwegen E, and Schubeler D. Modeling of epigenome dynamics identifies transcription factors that mediate polycomb targeting. Genome Res 23: 60-73, 2013.
5. Arrowsmith CH, Bountra C, Fish PV, Lee K, and Schapira M. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 11: 384-400, 2012.
6. Asp P, Blum R, Vethantham V, Parisi F, Micsinai M, Cheng J, Bowman C, Kluger Y, and Dynlacht BD. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci U S A 108: E149-E158, 2011.
7. Balemans MC, Huibers MM, Eikelenboom NW, Kuipers AJ, van Summeren RC, Pijpers MM, Tachibana M, Shinkai Y, van Bokhoven H, and Van der Zee CE. Reduced exploration, increased anxiety, and altered social behavior: autistic-like features of euchromatin histone methyltransferase 1 heterozygous knockout mice. Behav Brain Res 208: 47-55, 2010.
8. Ballare C, Lange M, Lapinaite A, Martin GM, Morey L, Pascual G, Liefke R, Simon B, Shi Y, Gozani O, Carlomagno T, Benitah SA, and Di Croce L. Phf19 links methylated Lys36 of histone H3 to regulation of polycomb activity. Nat Struct Mol Biol 19: 1257-1265, 2012.
9. Bannister AJ and Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 21: 381-395, 2011.
10. Bantignies F and Cavalli G. Polycomb group proteins: repression in 3D. Trends Genet 27: 454-464, 2011.
11. Bantignies F, Roure V, Comet I, Leblanc B, Schuettengruber B, Bonnet J, Tixier V, Mas A, and Cavalli G. Polycomb-dependent regulatory contacts between distant Hox loci in Drosophila. Cell 144: 214-226, 2011.
12. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, and Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837, 2007.
13. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, and Lander ES. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326, 2006.
14. Bilodeau S, Kagey MH, Frampton GM, Rahl PB, and Young RA. SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev 23: 2484-2489, 2009.
15. Black JC, Van Rechem C, and Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell 48: 491-507, 2012.
16. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, Bell GW, Otte AP, Vidal M, Gifford DK, Young RA, and Jaenisch R. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441: 349-353, 2006.
17. Bracken AP and Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 9: 773-784, 2009.
18. Brien GL, Gambero G, O'Connell DJ, Jerman E, Turner SA, Egan CM, Dunne EJ, Jurgens MC, Wynne K, Piao L, Lohan AJ, Ferguson N, Shi X, Sinha KM, Loftus BJ, Cagney G, and Bracken AP. Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation. Nat Struct Mol Biol 19: 1273-1281, 2012.
19. Brower-Toland B, Riddle NC, Jiang H, Huisinga KL, and Elgin SC. Multiple SET methyltransferases are required to maintain normal heterochromatin domains in the genome of Drosophila melanogaster. Genetics 181: 1303-1319, 2009.
20. Cai L, Rothbart SB, Lu R, Xu B, Chen WY, Tripathy A, Rockowitz S, Zheng D, Patel DJ, Allis CD, Strahl BD, Song J, and Wang GG. An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting. Mol Cell 49: 571-582, 2013.
21. Cao Q, Mani RS, Ateeq B, Dhanasekaran SM, Asangani IA, Prensner JR, Kim JH, Brenner JC, Jing X, Cao X, Wang R, Li Y, Dahiya A, Wang L, Pandhi M, Lonigro RJ, Wu YM, Tomlins SA, Palanisamy N, Qin Z, Yu J, Maher CA, Varambally S, and Chinnaiyan AM. Coordinated regulation of polycomb group complexes through micro-RNAs in cancer. Cancer Cell 20: 187-199, 2011.
22. Cao R and Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 15: 57-67, 2004.
23. Caretti G, Di Padova M, Micales B, Lyons GE, and Sartorelli V. The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 18: 2627-2638, 2004.
24. Chamberlain SJ, Yee D, and Magnuson T. Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells 26: 1496-1505, 2008.
25. Chaturvedi CP, Somasundaram B, Singh K, Carpenedo RL, Stanford WL, Dilworth FJ, and Brand M. Maintenance of gene silencing by the coordinate action of the H3K9 methyltransferase G9a/KMT1C and the H3K4 demethylase Jarid1a/KDM5A. Proc Natl Acad Sci U S A 109: 18845-18850, 2012.
26. Chen J, Liu H, Liu J, Qi J, Wei B, Yang J, Liang H, Chen Y, Wu Y, Guo L, Zhu J, Zhao X, Peng T, Zhang Y, Chen S, Li X, Li D, Wang T, and Pei D. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet 45: 34-42, 2013.
27. Chen M-W, Hua K-T, Kao H-J, Chi C-C, Wei L-H, Johansson G, Shiah S-G, Chen P-S, Jeng Y-M, Cheng T-Y, Lai T-C, Chang J-S, Jan Y-H, Chien M-H, Yang C-J, Huang M-S, Hsiao M, and Kuo M-L. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res 70: 7830-7840, 2010.
28. Chen X, Skutt-Kakaria K, Davison J, Ou YL, Choi E, Malik P, Loeb K, Wood B, Georges G, Torok-Storb B, and Paddison PJ. G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. Genes Dev 26: 2499-2511, 2012.
29. Cho HS, Kelly JD, Hayami S, Toyokawa G, Takawa M, Yoshimatsu M, Tsunoda T, Field HI, Neal DE, Ponder BA, Nakamura Y, and Hamamoto R. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia 13: 676-684, 2011.
30. Collins R and Cheng X. A case study in cross-talk: the histone lysine methyltransferases G9a and GLP. Nucleic Acids Res 38: 3503-3511, 2010.
31. Collins RE, Northrop JP, Horton JR, Lee DY, Zhang X, Stallcup MR, and Cheng X. The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules. Nat Struct Mol Biol 15: 245-250, 2008.
32. Dietrich N, Lerdrup M, Landt E, Agrawal-Singh S, Bak M, Tommerup N, Rappsilber J, Sodersten E, and Hansen K. REST-mediated recruitment of polycomb repressor complexes in mammalian cells. PLoS Genet 8: e1002494, 2012.
33. Ding J, Li T, Wang X, Zhao E, Choi JH, Yang L, Zha Y, Dong Z, Huang S, Asara JM, Cui H, and Ding HF. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab 18: 896-907, 2013.
34. Dodge JE, Kang YK, Beppu H, Lei H, and Li E. Histone H3-K9 methyltransferase ESET is essential for early development. Mol Cell Biol 24: 2478-2486, 2004.
35. Dong C, Wu Y, Yao J, Wang Y, Yu Y, Rychahou PG, Evers BM, and Zhou BP. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest 122: 1469-1486, 2012.
36. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T, Lorkiewicz P, St. Clair D, Hung MC, Evers BM, and Zhou BP. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23: 316-331, 2013.
37. Endoh M, Endo TA, Endoh T, Isono K, Sharif J, Ohara O, Toyoda T, Ito T, Eskeland R, Bickmore WA, Vidal M, Bernstein BE, and Koseki H. Histone H2A mono-ubiquitination is a crucial step to mediate PRC1-dependent repression of developmental genes to maintain ES cell identity. PLoS Genet 8: e1002774, 2012.
38. Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J, Deplus R, Fuks F, Shinkai Y, Cedar H, and Bergman Y. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 15: 1176-1183, 2008.
39. Eskeland R, Leeb M, Grimes GR, Kress C, Boyle S, Sproul D, Gilbert N, Fan Y, Skoultchi AI, Wutz A, and Bickmore WA. Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. Mol Cell 38: 452-464, 2010.
40. Ezhkova E, Lien WH, Stokes N, Pasolli HA, Silva JM, and Fuchs E. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev 25: 485-498, 2011.
41. Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su IH, Hannon G, Tarakhovsky A, and Fuchs E. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 136: 1122-1135, 2009.
42. Fang R, Barbera AJ, Xu Y, Rutenberg M, Leonor T, Bi Q, Lan F, Mei P, Yuan GC, Lian C, Peng J, Cheng D, Sui G, Kaiser UB, Shi Y, and Shi YG. Human LSD2/KDM1b/ AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol Cell 39: 222-233, 2010.
43. Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y, Cedar H, and Bergman Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 8: 188-194, 2006.
44. Ferrari KJ, Scelfo A, Jammula S, Cuomo A, Barozzi I, Stutzer A, Fischle W, Bonaldi T, and Pasini D. Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity. Mol Cell 53: 49-62, 2014.
45. Fragola G, Germain PL, Laise P, Cuomo A, Blasimme A, Gross F, Signaroldi E, Bucci G, Sommer C, Pruneri G, Mazzarol G, Bonaldi T, Mostoslavsky G, Casola S, and Testa G. Cell reprogramming requires silencing of a core subset of polycomb targets. PLoS Genet 9: e1003292, 2013.
46. Francis NJ, Kingston RE, and Woodcock CL. Chromatin compaction by a polycomb group protein complex. Science 306: 1574-1577, 2004.
47. Fritsch L, Robin P, Mathieu JR, Souidi M, Hinaux H, Rougeulle C, Harel-Bellan A, Ameyar-Zazoua M, and Ait-Si-Ali S. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol Cell 37: 46-56, 2010.
48. Greer EL and Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 13: 343-357, 2012.
49. Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W, Eussen BH, de Klein A, Wessels L, de Laat W, and van Steensel B. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453: 948-951, 2008.
50. Herranz N, Pasini D, Diaz VM, Franci C, Gutierrez A, Dave N, Escriva M, Hernandez-Munoz I, Di Croce L, Helin K, Garcia de Herreros A, and Peiro S. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol Cell Biol 28: 4772-4781, 2008.
51. Huang J, Dorsey J, Chuikov S, Perez-Burgos L, Zhang X, Jenuwein T, Reinberg D, and Berger SL. G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem 285: 9636-9641, 2010.
52. Iwase S and Shi Y. Histone and DNA modifications in mental retardation. Prog Drug Res 67: 147-173, 2011.
53. Jones PA and Baylin SB. The epigenomics of cancer. Cell 128: 683-692, 2007.
54. Juan AH, Derfoul A, Feng X, Ryall JG, Dell'Orso S, Pasut A, Zare H, Simone JM, Rudnicki MA, and Sartorelli V. Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells. Genes Dev 25: 789-794, 2011.
55. Juan AH, Kumar RM, Marx JG, Young RA, and Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 36: 61-74, 2009.
56. Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, Bourgey M, Bourque G, Montpetit A, Bourret G, Lepage P, Fleming A, Lichter P, Kool M, von Deimling A, Sturm D, Korshunov A, Faury D, Jones DT, Majewski J, Pfister SM, Jabado N, and Hawkins C. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124: 439-447, 2012.
57. Kim H, Kang K, and Kim J. AEBP2 as a potential targeting protein for polycomb repression complex PRC2. Nucleic Acids Res 37: 2940-2950, 2009.
58. Kind J, Pagie L, Ortabozkoyun H, Boyle S, de Vries SS, Janssen H, Amendola M, Nolen LD, Bickmore WA, and van Steensel B. Single-cell dynamics of genome-nuclear lamina interactions. Cell 153: 178-192, 2013.
59. Kleefstra T, Brunner HG, Amiel J, Oudakker AR, Nillesen WM, Magee A, Genevieve D, Cormier-Daire V, van Esch H, Fryns JP, Hamel BC, Sistermans EA, de Vries BB, and van Bokhoven H. Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet 79: 370-377, 2006.
60. Kleefstra T, Smidt M, Banning MJ, Oudakker AR, Van Esch H, de Brouwer AP, Nillesen W, Sistermans EA, Hamel BC, de Bruijn D, Fryns JP, Yntema HG, Brunner HG, de Vries BB, and van Bokhoven H. Disruption of the gene euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J Med Genet 42: 299-306, 2005.
61. Kleefstra T, van Zelst-Stams WA, Nillesen WM, Cormier-Daire V, Houge G, Foulds N, van Dooren M, Willemsen MH, Pfundt R, Turner A, Wison M, McGaughran J, Rauch A, Zenker M, Adam MP, Innes M, Davies C, López AG, Casalone R, Weber A, Brueton LA, Navarro AD, Bralo MP, Venselaar H, Stegmann SP, Yntema HG, van Bokhoven H, Brunner HG. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contributor of EHMT1 haploinsufficiency to the core phenotype. J Med Genet 46: 598-606, 2009.
62. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, and Chinnaiyan AM. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 100: 11606-11611, 2003.
63. Kondo Y, Shen L, Ahmed S, Boumber Y, Sekido Y, Haddad BR, and Issa JP. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PloS One 3: e2037, 2008.
64. Kouzarides T. Chromatin modifications and their function. Cell 128: 693-705, 2007.
65. Klamer JM, van Bokhoven H. Genetic and epigenetic defects in mental retardation. Int J Biochem Cell Biol 41: 96-107, 2009.
66. Ku M, Koche RP, Rheinbay E, Mendenhall EM, Endoh M, Mikkelsen TS, Presser A, Nusbaum C, Xie X, Chi AS, Adli M, Kasif S, Ptaszek LM, Cowan CA, Lander ES, Koseki H, and Bernstein BE. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 4: e1000242, 2008.
67. Lachner M, O'Carroll D, Rea S, Mechtler K, and Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116-120, 2001.
68. Landeira D, Sauer S, Poot R, Dvorkina M, Mazzarella L, Jorgensen HF, Pereira CF, Leleu M, Piccolo FM, Spivakov M, Brookes E, Pombo A, Fisher C, Skarnes WC, Snoek T, Bezstarosti K, Demmers J, Klose RJ, Casanova M, Tavares L, Brockdorff N, Merkenschlager M, and Fisher AG. Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators. Nat Cell Biol 12: 618-624, 2010.
69. Lee JS, Kim Y, Kim IS, Kim B, Choi HJ, Lee JM, Shin HJ, Kim JH, Kim JY, Seo SB, Lee H, Binda O, Gozani O, Semenza GL, Kim M, Kim KI, Hwang D, and Baek SH. Negative regulation of hypoxic responses via induced Reptin methylation. Mol Cell 39: 71-85, 2010.
70. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K, Koseki H, Fuchikami T, Abe K, Murray HL, Zucker JP, Yuan B, Bell GW, Herbolsheimer E, Hannett NM, Sun K, Odom DT, Otte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R, and Young RA. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125: 301-313, 2006.
71. Lehnertz B, Pabst C, Su L, Miller M, Liu F, Yi L, Zhang R, Krosl J, Yung E, Kirschner J, Rosten P, Underhill TM, Jin J, Hebert J, Sauvageau G, Humphries RK, and Rossi FM. The methyltransferase G9a regulates HoxA9-dependent transcription in AML. Genes Dev 28: 317-327, 2014.
72. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, and Peters AH. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13: 1192-1200, 2003.
73. Lewis PW, Muller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, Garcia BA, Muir TW, Becher OJ, and Allis CD. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340: 857-861, 2013.
74. Li G, Margueron R, Ku M, Chambon P, Bernstein BE, and Reinberg D. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev 24: 368-380, 2010.
75. Li H, Rauch T, Chen ZX, Szabo PE, Riggs AD, and Pfeifer GP. The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem 281: 19489-19500, 2006.
76. Li J, Hart RP, Mallimo EM, Swerdel MR, Kusnecov AW, and Herrup K. EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia. Nat Neurosci 16: 1745-1753, 2013.
77. Li J, Lin Q, Yoon HG, Huang ZQ, Strahl BD, Allis CD, and Wong J. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol Cell Biol 22: 5688-5697, 2002.
78. Li Q, Su Z, Xu X, Liu G, Song X, Wang R, Sui X, Liu T, Chang X, and Huang D. AS1DHRS4, a head-to-head natural antisense transcript, silences the DHRS4 gene cluster in cis and trans. Proc Natl Acad Sci U S A 109: 14110-14115, 2012.
79. Ling BM, Bharathy N, Chung TK, Kok WK, Li S, Tan YH, Rao VK, Gopinadhan S, Sartorelli V, Walsh MJ, and Taneja R. Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc Natl Acad Sci U S A 109: 841-846, 2012.
80. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL, Novak AJ, Dogan A, Ansell SM, Link BK, Zou L, Gould J, Saksena G, Stransky N, Rangel-Escareno C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Hernandez-Lemus E, Schwarz-Cruz y Celis A, Imaz-Rosshandler I, Ojesina AI, Jung J, Pedamallu CS, Lander ES, Habermann TM, Cerhan JR, Shipp MA, Getz G, and Golub TR. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 109: 3879-3884, 2012.
81. Loyola A, Tagami H, Bonaldi T, Roche D, Quivy JP, Imhof A, Nakatani Y, Dent SYR, and Almouzni G. The HP1a-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin. EMBO Rep 10: 769-775, 2009.
82. Lynch MD, Smith AJ, De Gobbi M, Flenley M, Hughes JR, Vernimmen D, Ayyub H, Sharpe JA, Sloane-Stanley JA, Sutherland L, Meek S, Burdon T, Gibbons RJ, Garrick D, and Higgs DR. An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate polycomb complex recruitment. EMBO J 31: 317-329, 2012.
83. Margueron R, Li G, Sarma K, Blais A, Zavadil J, Woodcock CL, Dynlacht BD, and Reinberg D. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol Cell 32: 503-518, 2008.
84. Margueron R and Reinberg D. The polycomb complex PRC2 and its mark in life. Nature 469: 343-349, 2011.
85. Maze I, Covington HE, 3rd, Dietz DM, LaPlant Q, Renthal W, Russo SJ, Mechanic M, Mouzon E, Neve RL, Haggarty SJ, Ren Y, Sampath SC, Hurd YL, Greengard P, Tarakhovsky A, Schaefer A, and Nestler EJ. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327: 213-216, 2010.
86. McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS, Liu Y, Graves AP, Della Pietra A, 3rd, Diaz E, LaFrance LV, Mellinger M, Duquenne C, Tian X, Kruger RG, McHugh CF, Brandt M, Miller WH, Dhanak D, Verma SK, Tummino PJ, and Creasy CL. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492: 108-112, 2012.
87. Mendenhall EM, Koche RP, Truong T, Zhou VW, Issac B, Chi AS, Ku M, and Bernstein BE. GC-rich sequence elements recruit PRC2 in mammalian ES cells. PLoS Genet 6: e1001244, 2010.
88. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, and Bernstein BE. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560, 2007.
89. Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, Stadler MB, Bibel M, and Schubeler D. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 30: 755-766, 2008.
90. Moore KE, Carlson SM, Camp ND, Cheung P, James RG, Chua KF, Wolf-Yadlin A, and Gozani O. A general molecular affinity strategy for global detection and proteomic analysis of lysine methylation. Mol Cell 50: 444-456, 2013.
91. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, Kimbara M, Shashkin P, Charlot JF, Tcherpakov M, Corbett R, Tam A, Varhol R, Smailus D, Moksa M, Zhao Y, Delaney A, Qian H, Birol I, Schein J, Moore R, Holt R, Horsman DE, Connors JM, Jones S, Aparicio S, Hirst M, Gascoyne RD, and Marra MA. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42: 181-185, 2010.
92. Mousavi K, Zare H, Wang AH, and Sartorelli V. Polycomb protein Ezh1 promotes RNA polymerase II elongation. Mol Cell 45: 255-262, 2012.
93. Mozzetta C, Consalvi S, Saccone V, Forcales SV, Puri PL, and Palacios D. Selective control of Pax7 expression by TNF-activated p38alpha/polycomb repressive complex 2 (PRC2) signaling during muscle satellite cell differentiation. Cell Cycle 10: 191-198, 2011.
94. Mozzetta C, Pontis J, Fritsch L, Robin P, Portoso M, Proux C, Margueron R, and Ait-Si-Ali S. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing. Mol Cell 53: 277-289, 2014.
95. Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, Feil R, and Fraser P. The air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322: 1717-1720, 2008.
96. Negre N, Hennetin J, Sun LV, Lavrov S, Bellis M, White KP, and Cavalli G. Chromosomal distribution of PcG proteins during Drosophila development. PLoS Biol 4: e170, 2006.
97. Nekrasov M, Klymenko T, Fraterman S, Papp B, Oktaba K, Kocher T, Cohen A, Stunnenberg HG, Wilm M, and Muller J. Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at polycomb target genes. EMBO J 26: 4078-4088, 2007.
98. Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, Tonnissen ER, van der Heijden A, Scheele TN, Vandenberghe P, de Witte T, van der Reijden BA, and Jansen JH. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet 42: 665-667, 2010.
99. Ntziachristos P, Tsirigos A, Van Vlierberghe P, Nedjic J, Trimarchi T, Flaherty MS, Ferres-Marco D, da Ros V, Tang Z, Siegle J, Asp P, Hadler M, Rigo I, De Keersmaecker K, Patel J, Huynh T, Utro F, Poglio S, Samon JB, Paietta E, Racevskis J, Rowe JM, Rabadan R, Levine RL, Brown S, Pflumio F, Dominguez M, Ferrando A, and Aifantis I. Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nat Med 18: 298-301, 2012.
100. O'Carroll D, Erhardt S, Pagani M, Barton SC, Surani MA, and Jenuwein T. The polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol 21: 4330-4336, 2001.
101. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, and Nakatani Y. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296: 1132-1136, 2002.
102. Ohno H, Shinoda K, Ohyama K, Sharp LZ, and Kajimura S. EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex. Nature 504: 163-167, 2013.
103. Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Marcarci BO, Unternaehrer J, Gupta PB, Lander ES, Armstrong SA, and Daley GQ. Chromatin-modifying enzymes as modulators of reprogramming. Nature 483: 598-602, 2012.
104. Osipovich O, Milley R, Meade A, Tachibana M, Shinkai Y, Krangel MS, and Oltz EM. Targeted inhibition of V(D)J recombination by a histone methyltransferase. Nat Immunol 5: 309-316, 2004.
105. Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V, Marquez VE, Valente S, Mai A, Forcales SV, Sartorelli V, and Puri PL. TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 7: 455-469, 2010.
106. Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, Jonsdottir GA, Stewart R, and Thomson JA. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1: 299-312, 2007.
107. Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, Nagano T, Mancini-Dinardo D, and Kanduri C. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 32: 232-246, 2008.
108. Pasini D, Bracken AP, Hansen JB, Capillo M, and Helin K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol Cell Biol 27: 3769-3779, 2007.
109. Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, and Helin K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 23: 4061-4071, 2004.
110. Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, Bak M, Tommerup N, Rappsilber J, and Helin K. JARID2 regulates binding of the polycomb repressive complex 2 to target genes in ES cells. Nature 464: 306-310, 2010.
111. Pasini D, Hansen KH, Christensen J, Agger K, Cloos PA, and Helin K. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and polycombrepressive complex 2. Genes Dev 22: 1345-1355, 2008.
112. Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, and Dalla-Favera R. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471: 189-195, 2011.
113. Patnaik D, Chin HG, Esteve PO, Benner J, Jacobsen SE, and Pradhan S. Substrate specificity and kinetic mechanism of mammalian G9a histone H3 methyltransferase. J Biol Chem 279: 53248-53258, 2004.
114. Pauler FM, Sloane MA, Huang R, Regha K, Koerner MV, Tamir I, Sommer A, Aszodi A, Jenuwein T, and Barlow DP. H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome. Genome Res 19: 221-233, 2009.
115. Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y, Sidow A, and Wysocka J. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139: 1290-1302, 2009.
116. Pereira CF, Piccolo FM, Tsubouchi T, Sauer S, Ryan NK, Bruno L, Landeira D, Santos J, Banito A, Gil J, Koseki H, Merkenschlager M, and Fisher AG. ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. Cell Stem Cell 6: 547-556, 2010.
117. Peric-Hupkes D, Meuleman W, Pagie L, Bruggeman SW, Solovei I, Brugman W, Graf S, Flicek P, Kerkhoven RM, van Lohuizen M, Reinders M, Wessels L, and van Steensel B. Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol Cell 38: 603-613, 2010.
118. Peters AH, Kubicek S, Mechtler K, O'Sullivan RJ, Derijck AA, Perez-Burgos L, Kohlmaier A, Opravil S, Tachibana M, Shinkai Y, Martens JH, and Jenuwein T. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 12: 1577-1589, 2003.
119. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, and Jenuwein T. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107: 323-337, 2001.
120. Plath K, Fang J, Mlynarczyk-Evans SK, Cao R, Worringer KA, Wang H, de la Cruz CC, Otte AP, Panning B, and Zhang Y. Role of histone H3 lysine 27 methylation in X inactivation. Science 300: 131-135, 2003.
121. Puri PL and Sartorelli V. Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and posttranscriptional modifications. J Cell Physiol 185: 155-173, 2000.
122. Rathert P, Dhayalan A, Murakami M, Zhang X, Tamas R, Jurkowska R, Komatsu Y, Shinkai Y, Cheng X, and Jeltsch A. Protein lysine methyltransferase G9a acts on non-histone targets. Nat Chem Biol 4: 344-346, 2008.
123. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, Mechtler K, Ponting CP, Allis CD, and Jenuwein T. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406: 593-599, 2000.
124. Regha K, Sloane MA, Huang R, Pauler FM, Warczok KE, Melikant B, Radolf M, Martens JH, Schotta G, Jenuwein T, and Barlow DP. Active and repressive chromatin are interspersed without spreading in an imprinted gene cluster in the mammalian genome. Mol Cell 27: 353-366, 2007.
125. Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, Shinkai Y, and Allis CD. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 12: 1591-1598, 2003.
126. Ringrose L, Rehmsmeier M, Dura JM, and Paro R. Genome-wide prediction of polycomb/trithorax response elements in Drosophila melanogaster. Dev Cell 5: 759-771, 2003.
127. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, and Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323, 2007.
128. Roopra A, Qazi R, Schoenike B, Daley TJ, and Morrison JF. Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. Mol Cell 14: 727-738, 2004.
129. Sampath SC, Marazzi I, Yap KL, Krutchinsky AN, Mecklenbrauker I, Viale A, Rudensky E, Zhou MM, Chait BT, and Tarakhovsky A. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol Cell 27: 596-608, 2007.
130. Sarma K, Margueron R, Ivanov A, Pirrotta V, and Reinberg D. Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo. Mol Cell Biol 28: 2718-2731, 2008.
131. Schaefer A, Sampath SC, Intrator A, Min A, Gertler TS, Surmeier DJ, Tarakhovsky A, and Greengard P. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 64: 678-691, 2009.
132. Schwartz YB, Kahn TG, Nix DA, Li XY, Bourgon R, Biggin M, and Pirrotta V. Genome-wide analysis of polycomb targets in Drosophila melanogaster. Nat Genet 38: 700-705, 2006.
133. Schwartz YB and Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 8: 9-22, 2007.
134. Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, Jager N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Fruhwald MC, Roggendorf W, Kramm C, Durken M, Atkinson J, Lepage P, Montpetit A, Zakrzewska M, Zakrzewski K, Liberski PP, Dong Z, Siegel P, Kulozik AE, Zapatka M, Guha A, Malkin D, Felsberg J, Reifenberger G, von Deimling A, Ichimura K, Collins VP, Witt H, Milde T, Witt O, Zhang C, Castelo-Branco P, Lichter P, Faury D, Tabori U, Plass C, Majewski J, Pfister SM, and Jabado N. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482: 226-231, 2012.
135. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devarakonda S, Conroe HM, Erdjument- Bromage H, Tempst P, Rudnicki MA, Beier DR, and Spiegelman BM. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454: 961-967, 2008.
136. Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR, Yuan GC, Lee Y, and Orkin SH. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 139: 1303-1314, 2009.
137. Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, Mao X, Yuan GC, and Orkin SH. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell 32: 491-502, 2008.
138. Shi Y, Sawada J, Sui G, Affar el B, Whetstine JR, Lan F, Ogawa H, Luke MP, Nakatani Y, and Shi Y. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422: 735-738, 2003.
139. Shinkai Y and Tachibana M. H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 25: 781-788, 2011.
140. Shirato H, Ogawa S, Nakajima K, Inagawa M, Kojima M, Tachibana M, Shinkai Y, and Takeuchi T. A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9. J Biol Chem 284: 733-739, 2009.
141. Simon C, Chagraoui J, Krosl J, Gendron P, Wilhelm B, Lemieux S, Boucher G, Chagnon P, Drouin S, Lambert R, Rondeau C, Bilodeau A, Lavallée S, Sauvageau M, Hébert J, and Sauvageau G. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev 26: 651-656, 2012.
142. Simon JA and Kingston RE. Occupying chromatin: polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell 49: 808-824, 2013.
143. Sing A, Pannell D, Karaiskakis A, Sturgeon K, Djabali M, Ellis J, Lipshitz HD, and Cordes SP. A vertebrate polycomb response element governs segmentation of the posterior hindbrain. Cell 138: 885-897, 2009.
144. Sridharan R, Gonzales-Cope M, Chronis C, Bonora G, McKee R, Huang C, Patel S, Lopez D, Mishra N, Pellegrini M, Carey M, Garcia BA, and Plath K. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1gamma in reprogramming to pluripotency. Nat Cell Biol 15: 872-882, 2013.
145. Stock JK, Giadrossi S, Casanova M, Brookes E, Vidal M, Koseki H, Brockdorff N, Fisher AG, and Pombo A. Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol 9: 1428-1435, 2007.
146. Stojic L, Jasencakova Z, Prezioso C, Stutzer A, Bodega B, Pasini D, Klingberg R, Mozzetta C, Margueron R, Puri PL, Schwarzer D, Helin K, Fischle W, and Orlando V. Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells. Epigenetics Chromatin 4: 16, 2011.
147. Tachibana M, Sugimoto K, Fukushima T, and Shinkai Y. Set domain-containing protein, G9a, is a novel lysinepreferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem 276: 25309-25317, 2001.
148. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H, and Shinkai Y. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16: 1779-1791, 2002.
149. Tachibana M, Ueda J, Fukuda M, Takeda N, Ohta T, Iwanari H, Sakihama T, Kodama T, Hamakubo T, and Shinkai Y. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev 19: 815-826, 2005.
150. Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, Li J, Rao A, and Shi Y. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447: 601-605, 2007.
151. Tan M, Luo H, Lee S, Jin F, Yang JS, Montellier E, Buchou T, Cheng Z, Rousseaux S, Rajagopal N, Lu Z, Ye Z, Zhu Q, Wysocka J, Ye Y, Khochbin S, Ren B, and Zhao Y. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146: 1016-1028, 2011.
152. Tanay A, O'Donnell AH, Damelin M, and Bestor TH. Hyperconserved CpG domains underlie polycombbinding sites. Proc Natl Acad Sci U S A 104: 5521-5526, 2007.
153. Tolhuis B, de Wit E, Muijrers I, Teunissen H, Talhout W, van Steensel B, and van Lohuizen M. Genome-wide profiling of PRC1 and PRC2 polycomb chromatin binding in Drosophila melanogaster. Nat Genet 38: 694-699, 2006.
154. Towbin BD, Gonzalez-Aguilera C, Sack R, Gaidatzis D, Kalck V, Meister P, Askjaer P, and Gasser SM. Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery. Cell 150: 934-947, 2012.
155. Trojer P, Zhang J, Yonezawa M, Schmidt A, Zheng H, Jenuwein T, and Reinberg D. Dynamic histone H1 isotype 4 methylation and demethylation by histone lysine methyltransferase G9a/KMT1C and the jumonji domaincontaining JMJD2/KDM4 proteins. J Biol Chem 284: 8395-8405, 2009.
156. Ueda T, Sanada M, Matsui H, Yamasaki N, Honda ZI, Shih LY, Mori H, Inaba T, Ogawa S, and Honda H. EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms. Leukemia 26: 2557-2560, 2012.
157. Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-Si-Ali S, and Trouche D. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol Cell Biol 21: 6484-6494, 2001.
158. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, and Chinnaiyan AM. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629, 2002.
159. Vassen L, Fiolka K, and Moroy T. Gfi1b alters histone methylation at target gene promoters and sites of gamma-satellite containing heterochromatin. EMBO J 25: 2409-2419, 2006.
160. Vella P, Barozzi I, Cuomo A, Bonaldi T, and Pasini D. Yin Yang 1 extends the Myc-related transcription factors network in embryonic stem cells. Nucleic Acids Res 40: 3403-3418, 2012.
161. Wagschal A, Sutherland HG, Woodfine K, Henckel A, Chebli K, Schulz R, Oakey RJ, Bickmore WA, and Feil R. G9a histone methyltransferase contributes to imprinting in the mouse placenta. Mol Cell Biol 28: 1104-1113, 2008.
162. Walker E, Chang WY, Hunkapiller J, Cagney G, Garcha K, Torchia J, Krogan NJ, Reiter JF, and Stanford WL. Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation. Cell Stem Cell 6: 153-166, 2010.
163. Wang H, An W, Cao R, Xia L, Erdjument-Bromage H, Chatton B, Tempst P, Roeder RG, and Zhang Y. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol Cell 12: 475-487, 2003.
164. Wang J and Abate-Shen C. The MSX1 homeoprotein recruits G9a methyltransferase to repressed target genes in myoblast cells. PloS One 7: e37647, 2012.
165. Wang J, Kumar RM, Biggs VJ, Lee H, Chen Y, Kagey MH, Young RA, and Abate-Shen C. The Msx1 homeoprotein recruits polycomb to the nuclear periphery during development. Dev Cell 21: 575-588, 2011.
166. Weiss T, Hergeth S, Zeissler U, Izzo A, Tropberger P, Zee BM, Dundr M, Garcia BA, Daujat S, and Schneider R. Histone H1 variant-specific lysine methylation by G9a/ KMT1C and Glp1/KMT1D. Epigenetics Chromatin 3: 7, 2010.
167. Wen B, Wu H, Shinkai Y, Irizarry RA, and Feinberg AP. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 41: 246-250, 2009.
168. Woo CJ, Kharchenko PV, Daheron L, Park PJ, and Kingston RE. A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell 140: 99-110, 2010.
169. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Zhang J, Baker SJ, and St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44: 251-253, 2012.
170. Wu H, Chen X, Xiong J, Li Y, Li H, Ding X, Liu S, Chen S, Gao S, and Zhu B. Histone methyltransferase G9a contributes to H3K27 methylation in vivo. Cell Res 21: 365-367, 2011.
171. Xie H, Xu J, Hsu JH, Nguyen M, Fujiwara Y, Peng C, and Orkin SH. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. Cell Stem Cell 14: 68-80, 2014.
172. Yamamizu K, Fujihara M, Tachibana M, Katayama S, Takahashi A, Hara E, Imai H, Shinkai Y, and Yamashita JK. Protein kinase A determines timing of early differentiation through epigenetic regulation with G9a. Cell Stem Cell 10: 759-770, 2012.
173. Yokochi T, Poduch K, Ryba T, Lu J, Hiratani I, Tachibana M, Shinkai Y, and Gilbert DM. G9a selectively represses a class of late-replicating genes at the nuclear periphery. Proc Natl Acad Sci U S A 106: 19363-19368, 2009.
174. Yoon J, Lee KS, Park JS, Yu K, Paik SG, and Kang YK. dSETDB1 and SU(VAR)3-9 sequentially function during germline-stem cell differentiation in Drosophila melanogaster. PloS One 3: e2234, 2008.
175. Yu Y, Song C, Zhang Q, DiMaggio PA, Garcia BA, York A, Carey MF, and Grunstein M. Histone H3 lysine 56 methylation regulates DNA replication through its interaction with PCNA. Mol Cell 46: 7-17, 2012.
176. Yuan P, Han J, Guo G, Orlov YL, Huss M, Loh YH, Yaw LP, Robson P, Lim B, and Ng HH. Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev 23: 2507-2520, 2009.
177. Zdzieblo D, Li X, Lin Q, Zenke M, Illich DJ, Becker M, and Muller AM. Pcgf6, a polycomb group protein, regulates mesodermal lineage differentiation in murine ES cells and functions in IPS reprogramming. Stem Cells 2014 [Epub ahead of print]; DOI: 10.1002/stem.1826.
178. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds SB, Ulyanov A, Becksfort J, Gupta P, Huether R, Kriwacki RW, Parker M, McGoldrick DJ, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, Cheng C, Roberts S, Barbato MI, Campana D, Coustan-Smith E, Shurtleff SA, Raimondi SC, Kleppe M, Cools J, Shimano KA, Hermiston ML, Doulatov S, Eppert K, Laurenti E, Notta F, Dick JE, Basso G, Hunger SP, Loh ML, Devidas M, Wood B, Winter S, Dunsmore KP, Fulton RS, Fulton LL, Hong X, Harris CC, Dooling DJ, Ochoa K, Johnson KJ, Obenauer JC, Evans WE, Pui CH, Naeve CW, Ley TJ, Mardis ER, Wilson RK, Downing JR, and Mullighan CG. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481: 157-163, 2012.
179. Zhang Y, Teng F, Luo GZ, Wang M, Tong M, Zhao X, Wang L, Wang XJ, and Zhou Q. MicroRNA-323-3p regulates the activity of polycomb repressive complex 2 (PRC2) via targeting the mRNA of embryonic ectoderm development (Eed) gene in mouse embryonic stem cells. J Biol Chem 288: 23659-23665, 2013.
180. Zhao J, Sun BK, Erwin JA, Song JJ, and Lee JT. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322: 750-756, 2008.
181. Zhou W, Zhu P, Wang J, Pascual G, Ohgi KA, Lozach J, Glass CK, and Rosenfeld MG. Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol Cell 29: 69-80, 2008.